ALD(肾上腺脑白质营养不良)的临床试验
总计439288个结果
-
VerathonUniversity of Texas Southwestern Medical Center完全的
-
University of CologneUmm Al-Qura University完全的
-
Leipzig University Medical CenterEuropean Leukodystrophy Association完全的
-
Li Zhang, MD招聘中诊断为 ALK 阳性 NSCLC | 第二代 ALK-TKI 耐药 | Ensatinib 在这部分患者中的疗效中国
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)招聘中
-
Boston Children's Hospital完全的
-
Takeda完全的癌,晚期 ALK+ 或 ROS1+ 非小细胞肺,肿瘤,晚期 ALK+ 或 ROS1+ 实体瘤西班牙, 意大利, 荷兰, 法国
-
Northern Arizona UniversityKidabilities Occupational Therapy Clinic未知
-
AbbVie招聘中
-
Université du Québec à Trois-RivièresFondation Chiropratique du Québec; Canadian Chiropractic Research Fondation完全的
-
Stony Brook University完全的
-
Medical College of WisconsinUniversity of Wisconsin, Milwaukee; Children's Hospital and Health System Foundation, Wisconsin 和其他合作者完全的
-
Pennine Acute Hospitals NHS TrustUniversity Hospitals, Leicester; University of Manchester; University of Salford未知
-
Medical University of South CarolinaEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)完全的
-
University of California, San FranciscoAmerican Society of Transplantation招聘中
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)招聘中
-
Sameek RoychowdhuryNational Cancer Institute (NCI)撤销局部晚期恶性实体瘤 | 转移性恶性实体瘤 | ALK基因突变 | 脑转移性恶性肿瘤 | 晚期恶性肿瘤 | ALK融合蛋白表达 | 中枢神经系统转移性恶性肿瘤 | ROS1基因突变 | ALK基因扩增 | ROS1融合阳性 | ROS1 基因扩增美国
-
RANDNational Institute on Alcohol Abuse and Alcoholism (NIAAA)完全的
-
Carl Zeiss Meditec, Inc.DataMed Devices Inc.完全的